Tianjin Century Pharmaceutical Co., Ltd. is a pharmaceutical company based in Tianjin, China, established in 2000. The company specializes in developing drugs, particularly focusing on areas such as nervous system diseases, endocrinology, metabolic diseases, and cardiovascular conditions. One of their notable drug developments includes Bendroflumethiazide, used to treat conditions like diabetes insipidus, with a mechanism based on inhibiting the thiazide-sensitive sodium-chloride cotransporter (NCC).